For healthcare providers, patients seeking natural alternatives, and pharmaceutical companies focused on botanical medicine, the treatment of common bacterial and inflammatory conditions like dysentery, gastroenteritis, tonsillitis, pharyngitis, and bronchitis is a constant need. While conventional antibiotics are often effective, concerns about antibiotic resistance and side effects have led many to explore traditional herbal remedies with a long history of safe use. One such remedy that has been standardized into a modern pharmaceutical form is andrographolide tablets. Derived from the plant Andrographis paniculata, a staple in Traditional Chinese Medicine and other Asian healing systems, andrographolide is the active compound responsible for the plant’s potent anti-inflammatory, anti-bacterial, and immune-modulating effects. As the global interest in evidence-based botanical medicine grows, the market for these tablets is on a steady and significant growth path.
Global Leading Market Research Publisher QYResearch announces the release of its latest report “Andrographolide Tablets – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Andrographolide Tablets market, including market size, share, demand, industry development status, and forecasts for the next few years. Building on a legacy of market intelligence since 2007, serving over 60,000 clients across six languages—with deep coverage in the pharmaceuticals, healthcare, and consumer goods sectors—QYResearch delivers the authoritative data needed to navigate this growing and therapeutically relevant market.
Market Size and Steady Growth Trajectory
The global market for Andrographolide Tablets was estimated to be worth US$ 20.7 million in 2024 and is forecast to a readjusted size of US$ 30 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031. This steady, above-average growth rate for a botanical pharmaceutical reflects the increasing acceptance of evidence-based herbal medicines and the continued high prevalence of the conditions they treat. The market analysis reveals that expansion is driven by growing consumer preference for natural remedies, the well-established efficacy of andrographolide for specific indications, and its integration into both professional healthcare and over-the-counter settings. Recent Q1 2026 data from key manufacturers in China confirms this robust trajectory, with steady demand from hospitals, clinics, and pharmacies for this versatile herbal tablet.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/4661928/andrographolide-tablets
What are Andrographolide Tablets?
Andrographolide tablets are a type of medicine whose main effects are used for bacterial dysentery, gastroenteritis, tonsillitis, pharyngitis, bronchitis, etc. They contain andrographolide, the key bioactive compound extracted from the plant Andrographis paniculata. Known as “Chuan Xin Lian” in TCM, this herb has a long history of use for treating infections and inflammation. The tablets offer a standardized, convenient dosage form of this potent botanical compound, making it accessible for modern medical use.
The market is segmented by the type of tablet formulation, which affects how the medication is taken and absorbed.
Segment by Type
Dispersible Tablets – These tablets can be dissolved in water before ingestion, which may be preferred for patients who have difficulty swallowing or for faster absorption.
Conventional Tablets – The standard solid tablet form, designed to be swallowed whole.
Market Segmentation and Key Players
The market is served by a range of Chinese pharmaceutical companies with expertise in producing botanical medicines. The Andrographolide Tablets market is segmented as below, featuring key players such as:
Chongqing Kerui Pharmaceutical (Group) Co., Ltd., Henan Furentang Pharmaceutical Co., Ltd., Wuxi Jiyushanwei Pharmaceutical Co., Ltd., Jiangxi Qingfeng Pharmaceutical Co., Ltd., Hainan Huipson Pharmaceutical Biotechnology Co., Ltd., Guangdong Wannianqing Pharmaceutical Co., Ltd., Sinopharm Group Yibin Pharmaceutical Co., Ltd., Quanzhou Zhongqiao Pharmaceutical Co., Ltd., Hubei Keyi Pharmaceutical Co., Ltd.
Segment by Application (End-User)
Hospital – A primary channel, where physicians prescribe andrographolide tablets for conditions like bronchitis, tonsillitis, and gastroenteritis.
Clinic – Clinics, particularly those focusing on primary care or TCM, are a key point of access for patients.
Other – Including retail pharmacies, TCM stores, and online platforms.
Key Characteristics Driving Market Development
Andrographolide tablets are a type of medicine whose main effects are used for bacterial dysentery, gastroenteritis, and respiratory infections. Several key characteristics define this market’s evolution.
1. A Broad Spectrum of Common Indications
The primary driver for andrographolide tablets is their effectiveness across a range of very common conditions: respiratory infections (bronchitis, tonsillitis, pharyngitis) and gastrointestinal infections (bacterial dysentery, gastroenteritis). This broad applicability gives the product a large potential patient base. Its use in both acute and recurrent conditions ensures steady demand.
2. The Appeal of a Natural, Botanical Alternative
Andrographolide tablets occupy a valuable niche as a natural alternative or adjunct to conventional antibiotics. For patients with mild to moderate infections, or for those seeking to reduce antibiotic use, it offers a treatment option rooted in traditional medicine but supported by modern research. This aligns with the global trend toward natural health products and integrative medicine.
3. Integration into Professional and Self-Care Channels
The product is used in both professional healthcare settings (hospitals, clinics) and for self-care via pharmacies. This dual-channel presence broadens its market reach. In hospitals and clinics, it may be prescribed by physicians familiar with its indications. In pharmacies, it may be recommended by pharmacists or sought out by informed consumers for self-treatment of common symptoms.
4. A Diverse and Competitive Domestic Supplier Base
The market features a number of Chinese pharmaceutical companies, creating a competitive landscape where brands may differentiate based on quality, price, reputation, and distribution networks. The presence of companies under the Sinopharm group umbrella indicates the involvement of major state-owned pharmaceutical enterprises, lending credibility to the product category.
5. Moderate International Growth Potential
While the primary market is China, andrographolide tablets have potential for international growth, particularly in markets with growing interest in herbal supplements and natural health products. In many Western countries, andrographolide is available as a dietary supplement. However, its classification as a medicine varies by region, affecting market access and marketing claims. The global trend toward evidence-based botanicals could support gradual expansion.
Strategic Outlook for Decision-Makers
For CEOs, Marketing Managers, and Investors, the narrative is clear: the andrographolide tablets market is a growing and therapeutically relevant segment of the botanical pharmaceutical industry, with a 5.5% CAGR offering a significant opportunity. Its expansion is driven by the high prevalence of the conditions it treats, the appeal of a natural alternative, and its integration into both professional and consumer channels.
The winners in this space will be those who can successfully:
- Maintain Consistent Quality and Potency: Uphold rigorous quality control standards to ensure consistent andrographolide content and tablet performance, building trust with healthcare professionals and consumers.
- Offer Convenient Dosage Forms: Cater to different patient preferences by offering both dispersible and conventional tablet formats, improving adherence and accessibility.
- Strengthen Relationships with Healthcare Channels: Foster ties with hospitals, clinics, and pharmacies to ensure the product is well-known and recommended for its key indications.
- Educate on Appropriate Use: Work with healthcare professionals to educate patients on the correct use of andrographolide tablets for common infections, reinforcing its role in self-care and primary treatment.
- Explore International Market Opportunities: For companies seeking growth, cautiously explore opportunities in international markets with favorable regulatory pathways for botanical medicines or dietary supplements, leveraging the growing global interest in natural health.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp








